tiprankstipranks
TNF Pharmaceuticals (TNFA)
NASDAQ:TNFA
Holding TNFA?
Track your performance easily

TNF Pharmaceuticals (TNFA) Income Statement

534 Followers

TNF Pharmaceuticals Income Statement

Last quarter (Q ), TNF Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, TNF Pharmaceuticals's net income was $-10.34M. See TNF Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
-----
Cost of Revenue
---$ -15.04M$ -2.01M
Gross Profit
---$ 15.04M$ 2.01M
Operating Expense
$ 8.70M$ 16.36M$ 15.28M$ 12.56M$ 5.10M
Operating Income
$ -15.78M$ -15.60M$ -15.28M$ -28.81M$ -9.49M
Net Non Operating Interest Income Expense
-$ -455.57K---
Other Income Expense
$ -8.92M$ 11.90M$ -76.54K$ -1.09M$ -141.00
Pretax Income
$ -19.49M$ -4.00M$ -15.20M$ -29.89M$ -9.49M
Tax Provision
-$ 4.13M$ -5.91M$ -6.22M$ -1.96M
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -23.00M$ -8.22M$ -15.21M$ -29.89M$ -9.49M
Basic EPS
$ -11.17$ -5.33$ -0.39$ -25.50$ -298.80
Diluted EPS
$ -11.17$ -5.33$ -0.39$ -25.50$ -298.80
Basic Average Shares
$ 7.26M$ 1.54M$ 38.83M$ 1.17M$ 117.54K
Diluted Average Shares
$ 7.26M$ 1.54M$ 38.83M$ 1.17M$ 117.54K
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 8.70M$ 16.36M$ 15.28M$ -2.48M$ 3.09M
Net Income From Continuing And Discontinued Operation
$ -20.65M$ -4.00M$ -15.20M$ -29.89M$ -9.49M
Normalized Income
$ -6.28M----
Interest Expense
-----
EBIT
$ -14.81M$ 129.05K$ -15.20M$ -29.28M$ -8.30M
EBITDA
$ -14.81M$ 129.05K$ -15.20M$ -29.28M$ -8.28M
Currency in USD

TNF Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis